Cargando…
Amblyomin-X induces ER stress, mitochondrial dysfunction, and caspase activation in human melanoma and pancreatic tumor cell
During the last two decades, new insights into proteasome function and its role in several human diseases made it a potential therapeutic target. In this context, Amblyomin-X is a Kunitz-type FXa inhibitor similar to endogenous tissue factor pathway inhibitor (TFPI) and is a novel proteasome inhibit...
Autores principales: | Morais, Katia L. P., Pacheco, Mario Thiego Fernandes, Berra, Carolina Maria, Bosch, Rosemary V., Sciani, Juliana Mozer, Chammas, Roger, de Freitas Saito, Renata, Iqbal, Asif, Chudzinski-Tavassi, Ana Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819916/ https://www.ncbi.nlm.nih.gov/pubmed/27015684 http://dx.doi.org/10.1007/s11010-016-2683-4 |
Ejemplares similares
-
Dynein Function and Protein Clearance Changes in Tumor Cells Induced by a Kunitz-Type Molecule, Amblyomin-X
por: Pacheco, Mario T. F., et al.
Publicado: (2014) -
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
por: Maria, Durvanei A., et al.
Publicado: (2018) -
Amblyomin-X, a recombinant Kunitz-type inhibitor, regulates cell adhesion and migration of human tumor cells
por: Schmidt, Mariana Costa Braga, et al.
Publicado: (2018) -
Modulation of stress and immune response by Amblyomin-X results in tumor cell death in a horse melanoma model
por: Lichtenstein, Flavio, et al.
Publicado: (2020) -
Structural and functional properties of the Kunitz-type and C-terminal domains of Amblyomin-X supporting its antitumor activity
por: Morais, K. L. P., et al.
Publicado: (2023)